Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023

SELL
$8.72 - $11.56 $898 - $1,190
-103 Reduced 0.07%
137,655 $1.53 Million
Q3 2022

Nov 01, 2022

SELL
$8.48 - $11.13 $2,315 - $3,038
-273 Reduced 0.2%
137,758 $1.17 Million
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $347,065 - $427,989
-34,881 Reduced 20.17%
138,031 $1.45 Million
Q1 2022

May 12, 2022

SELL
$9.81 - $15.4 $1.31 Million - $2.06 Million
-133,483 Reduced 43.57%
172,912 $1.88 Million
Q4 2021

Jan 21, 2022

BUY
$12.09 - $14.68 $813,608 - $987,905
67,296 Added 28.15%
306,395 $4.15 Million
Q3 2021

Nov 01, 2021

BUY
$13.25 - $15.13 $3.17 Million - $3.62 Million
239,099 New
239,099 $3.26 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track U.S. Capital Wealth Advisors, LLC Portfolio

Follow U.S. Capital Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.